Just a SNP away: The future of in vivo massively parallel reporter assay
The human genome is largely noncoding, yet the field is still grasping to understand how noncoding variants impact transcription and contribute to disease etiology. The massively parallel reporter assay (MPRA) has been employed to characterize the function of noncoding variants at unprecedented scal...
Saved in:
Main Authors: | Katherine N. Degner, Jessica L. Bell, Sean D. Jones, Hyejung Won |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Cell Insight |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772892724000695 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How will developmental neuroimaging contribute to the prediction of neurodevelopmental or psychiatric disorders? Challenges and opportunities
by: Koraly Pérez-Edgar, et al.
Published: (2025-01-01) -
Psychiatric Morbidity among Primary Caregivers of Children with Neurodevelopmental Disorders at a Teaching Hospital in Kenya
by: Louise Namusonge Lusimbo, et al.
Published: (2024-12-01) -
Feasibility of Ex Vivo Ligandomics
by: Prabuddha Waduge, et al.
Published: (2025-01-01) -
Development of Novel Formulations to Enhance in Vivo Transdermal Permeation of Tocopherol
by: Nada Aly H., et al.
Published: (2014-09-01) -
Methods of massive parallel reporter assays for investigation of enhancers
by: S. E. Romanov, et al.
Published: (2021-06-01)